[go: up one dir, main page]

AR061011A1 - Suspension acuosa estable - Google Patents

Suspension acuosa estable

Info

Publication number
AR061011A1
AR061011A1 ARP070102143A ARP070102143A AR061011A1 AR 061011 A1 AR061011 A1 AR 061011A1 AR P070102143 A ARP070102143 A AR P070102143A AR P070102143 A ARP070102143 A AR P070102143A AR 061011 A1 AR061011 A1 AR 061011A1
Authority
AR
Argentina
Prior art keywords
suspension
sweeteners
stable waterproof
waterproof suspension
sorbintán
Prior art date
Application number
ARP070102143A
Other languages
English (en)
Inventor
Lillian Cromie
Willy Blakely
Louise Reynolds
Original Assignee
Norbrook Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0610058A external-priority patent/GB0610058D0/en
Priority claimed from GB0610246A external-priority patent/GB0610246D0/en
Priority claimed from GB0708375A external-priority patent/GB2438287A/en
Application filed by Norbrook Lab Ltd filed Critical Norbrook Lab Ltd
Publication of AR061011A1 publication Critical patent/AR061011A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una suspension farmacéutica acuosa que comprende: (i) al menos un fármaco antiinflamatorio no esteroideo; como por ejemplo meloxicam; (ii) un sistema tamponante acuoso; (iii) goma xantano; ( iv) polivinilpirrolidona; y (v) glicerol, donde la suspension está libre de almidon pregelatinizado, ácido amino policarboxílico, celulosa microcristalina, hidroxipropilmetilcelulosa, monooleato de polioxietilen sorbintán, dioxido de silicio y agentes modificadores del sabor seleccionados entre el grupo que comprende edulcorantes de carga, edulcorantes intensos, agentes saborizantes y mezclas de ellos; procedimiento para fabricarla y su uso.
ARP070102143A 2006-05-19 2007-05-18 Suspension acuosa estable AR061011A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0610058A GB0610058D0 (en) 2006-05-19 2006-05-19 Stable aqueous suspension
GB0610246A GB0610246D0 (en) 2006-05-23 2006-05-23 Stable aqueous suspension
GB0708375A GB2438287A (en) 2006-05-19 2007-04-30 Stable aqueous suspension

Publications (1)

Publication Number Publication Date
AR061011A1 true AR061011A1 (es) 2008-07-30

Family

ID=38723651

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070102143A AR061011A1 (es) 2006-05-19 2007-05-18 Suspension acuosa estable

Country Status (8)

Country Link
EP (1) EP2034958B1 (es)
AP (1) AP2283A (es)
AR (1) AR061011A1 (es)
AU (1) AU2007253083B2 (es)
CA (1) CA2645205C (es)
PL (1) PL2034958T3 (es)
UY (1) UY30357A1 (es)
WO (1) WO2007135362A2 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9720061D0 (en) 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
MY157620A (en) 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
GB0714670D0 (en) 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
GB0720220D0 (en) 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
US20100179229A1 (en) * 2008-03-05 2010-07-15 Basf Se Method for modulating the taste of material compositions containing at least one high intensity sweetener (his)
EP3167875A1 (en) * 2009-05-27 2017-05-17 Alkermes Pharma Ireland Limited Reduction of flake-like aggregation in nanoparticulate meloxicam compositions
GB0913525D0 (en) 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
GB201001779D0 (en) 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition
WO2013022410A2 (en) 2011-08-08 2013-02-14 Mahmut Bilgic Production method for effervescent formulations comprising dexketoprofen
ITUB20155193A1 (it) * 2015-11-03 2017-05-03 Italfarmaco Spa Sospensioni orali di Givinostat fisicamente e chimicamente stabili
CN113925830B (zh) * 2017-08-24 2023-07-14 江苏恒瑞医药股份有限公司 一种包含美洛昔康的可注射的药物组合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050069590A1 (en) * 2003-09-30 2005-03-31 Buehler Gail K. Stable suspensions for medicinal dosages
EP1824493B1 (en) * 2004-12-06 2008-08-13 Janssen Pharmaceutica N.V. Oral suspension comprising meloxicam

Also Published As

Publication number Publication date
AP2008004691A0 (en) 2008-12-31
CA2645205C (en) 2012-12-04
AU2007253083B2 (en) 2012-07-19
EP2034958B1 (en) 2009-10-28
CA2645205A1 (en) 2007-11-29
AU2007253083A1 (en) 2007-11-29
EP2034958A2 (en) 2009-03-18
AP2283A (en) 2011-10-31
WO2007135362A2 (en) 2007-11-29
UY30357A1 (es) 2008-01-02
PL2034958T3 (pl) 2010-04-30
WO2007135362A3 (en) 2008-10-16

Similar Documents

Publication Publication Date Title
AR061011A1 (es) Suspension acuosa estable
CL2011000170A1 (es) Composicion farmaceutica solida y estabilizada que comprende un ingrediente farmaceuticamente activo, oxido de titanio y un plastificante; procedimiento para estabilizar la composicion farmaceutica durante una irradiacion luminosa.
CR10429A (es) Suspension acuosa estable
CL2012001298A1 (es) Compuestos derivados del acido carbomoil-metilamino acetico sustituido, inhibidores de nep; composicion farmaceutica; combinacion farmaceutica; y uso para el tratamiento de hipertension arterial, hipertension pulmonar, insuficiencia cardiaca, entre otras.
BRPI0414581C1 (pt) composto, composição farmacêutica compreendendo o referido composto e uso do referido composto
NO20081889L (no) Fast vaksine formulering
NO20093146L (no) Amino-pyridinderivater som S1P1/EDG1-reseptoragonister
EP2331072A4 (en) METHOD AND COMPOSITIONS FOR ORAL ADMINISTRATION OF PROTEINS
NO20081942L (no) Karbamoylbenzotriazolderivater som inhibitorer av lipaser og fosfolipaser
NO20075298L (no) Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
JP2010529999A5 (es)
NO20082793L (no) Nye tiofenderivater
ECSP066662A (es) Preparación farmacéutica que comprende un anticuerpo contra el receptor egf
CY1109320T1 (el) Σκευασμα εναιωρηματος φεξοφεναδινης
NO20083630L (no) Nye pyridinderivater
NO20081576L (no) Preparater og fremgangsmater for fremstilling av darlig vannloselige legemidler med okt stabilitet
EA033370B1 (ru) Составы рифаксимина и их применение
NO20075660L (no) Blanding for behandling av inflammatoriske sykdommer
TR200801336T1 (tr) Kararlılığı artmış zayıf su çöznurluğune sahip ilaçların preparasyonuna yönelik kompozisyonlar ve yöntemler.
AR067011A1 (es) Formulaciones de anticuerpos
ATE502921T1 (de) Substituierte indole
EA201071218A1 (ru) Улучшенные композиции для активных фармацевтических компонентов с плохой проницаемостью
PE20110943A1 (es) Formulacion oral solida de alisquireno
CY1116831T1 (el) ΧΡΗΣΗ 24-norUDCA
AR033293A1 (es) Composiciones y metodos para aumentar la biodisponibilidad de agentes farmaceuticos

Legal Events

Date Code Title Description
FB Suspension of granting procedure